Second, RIPC has been shown to decrease the expression of HIF-1α and HIF-2α in the ischemic brain and to decrease the protein levels of pro-inflammatory cytokines IL-1β and IFN-γ in both the blood and brain 48 h post-stroke. This evidence concerns the gene IL1B and Stroke.